Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PAPPA anticorps (AA 351-523)

L’anticorps Souris Monoclonal anti-PAPPA a été validé pour IHC (f). Il convient pour détecter PAPPA dans des échantillons de Humain.
N° du produit ABIN6938112

Aperçu rapide pour PAPPA anticorps (AA 351-523) (ABIN6938112)

Antigène

Voir toutes PAPPA Anticorps
PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

Reactivité

  • 102
  • 22
Humain

Hôte

  • 60
  • 47
  • 1
Souris

Clonalité

  • 61
  • 47
Monoclonal

Conjugué

  • 39
  • 15
  • 11
  • 8
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PAPPA est non-conjugé

Application

  • 51
  • 50
  • 33
  • 32
  • 13
  • 13
  • 10
  • 8
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

PAPPA-2715
  • Épitope

    • 15
    • 12
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 351-523

    Specificité

    Pregnancy Associated Plasma Protein (PAPP-A) is found in maternal blood that increases as pregnancy progresses, although it is not specific to pregnancy. It is principally expressed in the syncytiotrophoblast of the placenta, which forms the main source of circulating maternal PAPP-A. It cleaves insulin-like growth factor binding proteins (IGFBPs), IGFBP-4 and IGFBP-5. IGFBP-4 cleavage is enhanced significantly in the presence of bound IGF, whereas IGFBP-5 cleavage is inhibited slightly by IGF presence. It is thought to be involved in local proliferative processes such as wound healing and bone remodeling. Low plasma level of this protein has been suggested as a biochemical marker for pregnancies with aneuploid fetuses. PAPPA has also been suggested as a potential biomarker of acute myocardial infarction and Coronary Artery Disease (CAD).

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment (within aa 351-523) of human PAPP-A protein (exact sequence is proprietary)

    Isotype

    IgG2b kappa
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Placenta.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

    Autre désignation

    PAPPA

    Sujet

    ASBABP2, Aspecific BCL2 ARE binding protein 2, Differentially placenta 1 expressed protein, DIPLA1, IGF-dependent, IGFBP4ase, Insulin-like growth factor-dependent IGF-binding protein 4 protease (IGFBP-4 protease), PAPA, PAPP A, PAPPA1, Pappalysin-1, Pregnancy Associated Plasma Protein A (PAPP-A),PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus)
    Cellular localisation: Secreted

    Poids moléculaire

    181kDa

    ID gène

    5069, 643599

    UniProt

    Q13219
Vous êtes ici:
Chat with us!